Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants
During follow-up, newly diagnosed primitive or metastatic cancer in patients with NVAF taking DOACs is a strong predictor of major bleeding regardless of baseline hemorrhagic risk assessment. In contrast, such an association is not observed with malignancy at baseline. Appropriate diagnosis and treatment could therefore reduce the risk of cancer-related bleeding.
Authors
- Lisa Canton
- Lorenzo Bartoli (ORCID: https://orcid.org/0000-0002-8437-0222)
- Francesca Bodega
- Daniele Cavallo
- Carmine Pizzi (ORCID: https://orcid.org/0000-0002-4048-675X)
- Davide Bertolini (ORCID: https://orcid.org/0009-0009-2554-2512)
- Andrea Rinaldi (ORCID: https://orcid.org/0000-0003-3234-0563)
- Luca Bergamaschi (ORCID: https://orcid.org/0000-0001-8186-9717)
- Ilaria Caldarera
- Damiano Fedele (ORCID: https://orcid.org/0000-0002-9198-2817)
- Sara Amicone
- Angelo Sansonetti (ORCID: https://orcid.org/0000-0002-4565-4310)
- Francesco Pio Tattilo (ORCID: https://orcid.org/0009-0008-3709-5791)
- Khrystyna Ryabenko (ORCID: https://orcid.org/0000-0001-8254-1502)
- Daniela Paola Pomata
- Andrea Impellizzeri
- Marcello Casuso Alvarez
- Matteo Armillotta (ORCID: https://orcid.org/0000-0002-7971-8052)
- Francesco Angeli (ORCID: https://orcid.org/0000-0002-8732-4512)
- Ornella Di Iuorio (ORCID: https://orcid.org/0009-0000-6352-0490)
- Mariachiara Ciarlantini
- Virginia Marinelli
- Nicole Suma (ORCID: https://orcid.org/0009-0003-6119-8890)
- Claudio Asta
- Giuseppe Pastore
- Andrea Stefanizzi (ORCID: https://orcid.org/0009-0000-2711-4268)
Institutions
- Azienda USL di Bologna (IT)
- University of Bologna (IT)
Publication Details
- Journal
- American Journal of Cardiovascular Drugs
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1007/s40256-024-00676-y
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.40